Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
04/2003
04/15/2003US6547787 Drug delivery catheters that attach to tissue and methods for their use
04/15/2003US6546928 Metered dose inhaler for fluticasone propionate
04/15/2003CA2381329C Medicaments
04/15/2003CA2292797C Nanoemulsion with a base of fatty esters of glycerol and its cosmetic, dermatological and/or ophthalmological uses
04/15/2003CA2292796C Nanoemulsion with a base of fatty esters of oxyethylenated or non-oxyethylenated sorbitan, its cosmetic, dermatological and/or ophthalmological uses
04/15/2003CA2274338C Ziprasidone formulations
04/15/2003CA2259698C Trovafloxacin mesylate tablet
04/15/2003CA2196150C Process for the preparation of medicated chewing gum provided with a pleasant taste independent from the active agent incorporated therein
04/15/2003CA2190485C Lacrimal gland specific emulsions for topical application to ocular tissue
04/15/2003CA2120599C Transdermal therapeutic systems containing crystallization inhibitors
04/15/2003CA2112679C Dosage form for delivering drug in short-time period
04/15/2003CA2112487C Method and compositions for treating emesis, nausea and other disorders using optically pure r(+) ondansetron
04/15/2003CA2108018C Colloidal particles of water insoluble biologically active substances
04/15/2003CA2099588C Prevention of synovial adhesions
04/15/2003CA2079315C Device and method for iontophoretic drug delivery
04/11/2003WO2002030928A1 Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament
04/10/2003WO2003029417A2 Nutrient medium for maintaining neural cells in injured nervous system
04/10/2003WO2003029294A1 Spheroidal hdl particles with a defined phospholipid composition
04/10/2003WO2003029214A1 Pseudopolymorphic forms of carvedilol
04/10/2003WO2003028990A1 Systems, methods and apparatuses for manufacturing dosage forms
04/10/2003WO2003028989A1 Systems, methods and apparatuses for manufacturing dosage forms
04/10/2003WO2003028776A1 Sanitary napkins with hydrophobic lotions
04/10/2003WO2003028767A2 Water-in-oil emulsions comprising vinyl polymers carrying ethylene oxide groups in side chains, compositions and methods
04/10/2003WO2003028766A1 Water-in-oil emulsions comprising vinyl polymers carrying acidic groups in side chains, compositions, and methods
04/10/2003WO2003028765A1 Injections for eye tissue containing drug bound to polyethylene glycol
04/10/2003WO2003028760A2 Vaccine
04/10/2003WO2003028759A1 Rsv gene expression vaccine
04/10/2003WO2003028743A1 Storage-stable fibrinogen solutions
04/10/2003WO2003028736A2 Pharmaceutical preparations comprising alkyl phosphocholine compounds in liposomes which may be sterile-filtered or heat-sterilised
04/10/2003WO2003028723A1 Pharmaceutical compositions for percutaneous absorption containing fused imidazopyridine derivatives
04/10/2003WO2003028716A1 Aqueous ecabet sodium solution preparation
04/10/2003WO2003028708A1 Timed, sustained release multi-particulate dosage forms of propranolol
04/10/2003WO2003028707A1 Solid compositions comprising ramipril
04/10/2003WO2003028706A1 Press-coated molded article undergoing quick disintegration
04/10/2003WO2003028705A1 Pharmaceutical compositions comprising colloidal silicon dioxide
04/10/2003WO2003028704A1 Extended release pharmaceutical composition containing metformin
04/10/2003WO2003028703A2 Immediate release tablet
04/10/2003WO2003028702A1 Ibuprofen salt emulsifiers and cream formulations containing same
04/10/2003WO2003028701A2 Liposomes containing (ether)lysolecithins
04/10/2003WO2003028700A2 Water soluble nanoparticles of hydrophilic and hydrophobic active materials
04/10/2003WO2003028699A1 Compositions used to alleviate xerostomia and to treat disorders associated with same
04/10/2003WO2003028698A2 Method and device for producing granulates that comprise at least one pharmaceutical active substance
04/10/2003WO2003028697A2 Liposome loading with metal ions
04/10/2003WO2003028696A2 Compositions for delivery of drug combinations
04/10/2003WO2003028692A2 Acne treatment using oleanolic acid
04/10/2003WO2003028667A2 Semisolid topical hormonal compositions and methods for treatment
04/10/2003WO2003028662A2 A method of producing a processed kava product having an altered kavalactone distribution and processed kava products produced using the same
04/10/2003WO2003028660A2 Drug delivery devices and methods
04/10/2003WO2003028657A2 Compositions for oral gene therapy and methods of using same
04/10/2003WO2003028656A2 Adjuvant compositions
04/10/2003WO2003028654A2 Storage-stable human fibrinogen solutions
04/10/2003WO2003028653A2 Sustained release pharmaceutical compositions
04/10/2003WO2003028649A2 Novel composition of carvedilol
04/10/2003WO2003028645A2 Novel compositions of carvedilol
04/10/2003WO2003028633A2 Parenteral delivery systems
04/10/2003WO2003028624A2 Levothyroxine compositions and methods
04/10/2003WO2003028622A2 Method of delivering drugs to a tissue using drug-coated medical devices
04/10/2003WO2003028620A1 Method for making an insert
04/10/2003WO2003028619A2 Systems, methods and apparatuses for manufacturing dosage forms
04/10/2003WO2003028618A2 Systems, methods and apparatuses for manufacturing dosage forms
04/10/2003WO2003028600A1 Wipe formulation
04/10/2003WO2003028590A1 Rational drug therapy device and methods
04/10/2003WO2003028492A1 Encapsulated materials
04/10/2003WO2003015823B1 Novel microemulsion and micelle systems for solubilizing drugs
04/10/2003WO2003004062A9 Pharmaceutical formulations and ligands for use therein; mimetics for uea-1
04/10/2003WO2003002103A3 Hydrophobic dopamine agonists administered to the dermis
04/10/2003WO2003002092A3 Controlled release composition comprising lactic acid polymer and hydroxynaphthoic acid, and method of producing the same
04/10/2003WO2002100378A3 Process for the preparation of a particulate material
04/10/2003WO2002094189A3 Compositions and methods for treating or preventing convulsions or seizures
04/10/2003WO2002092064A3 Therapeutic method for inducing tolerance
04/10/2003WO2002090510A3 Regulating immine responses using dendritic cells
04/10/2003WO2002089699A3 Medical device and methods of use for glaucoma treatment
04/10/2003WO2002085326A3 Large, porous particles produced controlling humidity during a spray drying process
04/10/2003WO2002083208A3 Implantable therapeutic substance delivery device having a permanent magnet solenoid pump
04/10/2003WO2002083108A3 Compositions containing cgmp pde inhibitors and local anaesthetic agents for nasal application
04/10/2003WO2002083105A3 Composition for enhanced absorption of nsaids
04/10/2003WO2002083103A3 Pharmaceutical product with reticulated crystalline microstructure
04/10/2003WO2002083079A9 Aerosol compositions containing formoterol for delivery to the lungs via nebulization
04/10/2003WO2002074238A3 Water soluble and palatable complexes
04/10/2003WO2002060412A3 Stabilised polymeric aerosols for pulmonary gene delivery
04/10/2003WO2002045687A3 Topical alcoholic solution of a salicylic acid derivative and acemannan
04/10/2003WO2002045573A3 Condom with male genital desensitizer lubricant
04/10/2003WO2002043767A8 Improved oral delivery of peptides using enzyme-cleavable membrane translocators
04/10/2003WO2002036175A3 Sustained release device for treating conditions of the joint
04/10/2003WO2002009678A3 Charged phospholipid compositions and methods for their use
04/10/2003WO2001087295A8 Methods for decreasing cell proliferation based on (3r, 4r)-δ8-tetrahydrocannabinol-11-oic acids
04/10/2003US20030069614 Ambulatory medical apparatus and method using a telemetry system with predefined reception listening
04/10/2003US20030069563 Medical dressing assembly and associated method of using the same
04/10/2003US20030069560 Implantable drug delivery device and use thereof
04/10/2003US20030069548 Microdevice and method of delivering of withdrawing a substance through the skin of an animal
04/10/2003US20030069484 Optical sampling interface system for in vivo measurement of tissue
04/10/2003US20030069318 Salts of analgesic substances in oil, and methods of making and using the same
04/10/2003US20030069313 Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue
04/10/2003US20030069312 Nitromethyl ketones, process for preparing them and compositions containing them
04/10/2003US20030069308 Antidiabetic agents
04/10/2003US20030069307 Oxidation resistance; free radical scavenger; foods, drugs, cosmetics
04/10/2003US20030069301 Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
04/10/2003US20030069280 S(-)rabeprazole compositions and methods
04/10/2003US20030069272 Prevent joint stiffness; adjust concentration of synovial fluid
04/10/2003US20030069271 Quinolone compounds for use in treating viral infections
1 ... 2155 2156 2157 2158 2159 2160 2161 2162 2163 2164 2165 2166 2167 2168 2169 2170 2171 2172 2173 2174 2175 ... 2991